Shorted

Nanollose (NC6) Short Interest

Nanollose (ASX:NC6) had 0.00% of shares reported as short positions as of 1 Oct 2026, representing 1,214 shares. Nanollose operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Nanollose logo
NC6

Nanollose

Pharmaceuticals, Biotechnology & Life Sciences

Nanollose is an Australian biotechnology company focused on developing sustainable materials, particularly Nullarbor fibre, a tree-free rayon alternative made from microbial cellulose. Their technology aims to transform liquid waste into rayon fibre for clothing, minimizing environmental impact and offering a scalable solution for the textile industry. The company is positioned to capitalize on the growing demand for eco-friendly and sustainable textile options.

Short position

short percentage0.00%
reported shorts1.2K
shares on issue409.827M

Nanollose (ASX:NC6) has 0.00% of its shares on issue reported as short positions as of 1 Oct 2026, or about 1,214 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. NC6 is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 40, 2026.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

NC6 intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required
Short interest history & FAQ

NC6 Short Interest History

30-day change
-0.00pp
90-day change
-0.00pp
1-year change
-0.00pp
All-time high
0.01% (February 2026)
All-time low
0.00% (October 2026)

Is NC6 heavily shorted?

Not especially: 0.00% short interest is modest by ASX standards, ranking #702 of 803 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.

How has NC6's short interest changed recently?

Over the past 30 days Nanollose's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.

What is the highest NC6's short interest has been?

Since 2024, Nanollose's short interest peaked at 0.01% in February 2026 and bottomed at 0.00% in October 2026.

Where does this data come from?

All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2024. See our methodology.

NC6 fundamentals

In the year to 30 Jun 2026, Nanollose (ASX:NC6) recorded revenue of A$3.5K and a net loss after tax of A$2.4M. A year earlier it recorded revenue of A$11.9K and a net loss after tax of A$1.4M. Year-on-year growth: revenue −70.4% (FY). Net margin −67,628.0% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 29 Sep 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Strategy fit

How each stock picker strategy reads NC6 today

PassFailUnknown (data missing, or not meaningful for this company)

  • Zanger Breakout

    WatchScore 16rank 1496 of 1959

    • 1. Explosive growth: fail. Revenue -70.4% YoY (FY ending 2026-06-30); still loss-making on EPS (12 months to 2026-06-30); below the +25% threshold
    • 2. A recognisable base: pass. 35-session base, 16.2% deep; close A$0.07 holds above the base low A$0.07
    • 3. Breakout on heavy volume: fail. No close above the A$0.08 pivot on 1.5x volume in the last 5 sessions; close is -10.0% from the pivot
    • 4. Read the market first: fail. XJO in a downtrend: below its 200-day average
    • 5. Relative strength: fail. Lagged the S&P/ASX 200 by 0.5 points over 3 months
    • 6. Liquid enough to trade: fail. A$5k average daily turnover over 20 sessions, below the A$250k floor
  • CAN SLIM

    Not a candidate

    • 1. Earnings growth (C and A): fail. Still loss-making on EPS (12 months to 2026-06-30)
    • 2. Sales growth: fail. Revenue -70.4% YoY (FY ending 2026-06-30); below the +20% threshold
    • 3. New highs (N): fail. 13.3% below the 52-week high, more than 5% away
    • 4. Leader, not laggard (L): fail. 6-month relative strength -1.4 points, below the top-quartile cut-off of +7.7
    • 5. Market direction (M): fail. XJO in a downtrend: below its 200-day average
    • 6. Supply and demand (S): fail. A$5k average daily turnover over 20 sessions, below the A$250k floor
  • Minervini Trend Template

    WatchScore 34rank 516 of 1789

    • 1. Above rising averages: fail. Close A$0.07, 150-day A$0.07, 200-day A$0.07: close is not above the 150-day
    • 2. 200-day trending up: pass. 200-day average A$0.07 vs A$0.07 a month ago (+4.9%)
    • 3. Well off the low: pass. Close A$0.07 is 89.5% above the 52-week low of A$0.04
    • 4. Near the high: pass. 13.3% below the 52-week high
    • 5. Relative strength: fail. 6-month relative strength -1.4 points, below the top-quartile cut-off of +7.7
    • 6. Above the 50-day: fail. Close A$0.07 vs 50-day average A$0.08 (-4.3%)
    • 7. Liquid enough to trade: fail. A$5k average daily turnover over 20 sessions, below the A$250k floor
  • Crowded-Short Breakout

    Not a candidate

    • 1. Crowded short: fail. 0.00% of shares on issue reported short, under 5%
    • 2. Days to cover: fail. 0.0 days of average volume to cover, under 5
    • 3. Breakout on heavy volume: fail. No close above the A$0.08 pivot on 1.5x volume in the last 5 sessions; close is -10.0% from the pivot
    • 4. Market direction: fail. XJO in a downtrend: below its 200-day average
    • 5. Liquid enough to trade: fail. A$5k average daily turnover over 20 sessions, below the A$250k floor
    • 6. Relative strength: fail. Lagged the S&P/ASX 200 by 0.5 points over 3 months
  • Quality compounders

    WatchScore 10rank 1369 of 1687

    • 1. High return on equity: unknown. Return on equity cannot be measured: it needs net profit, equity at both ends of the year and, outside banks, insurers and other financials, equity of at least 10% of total assets
    • 2. Healthy profit margin: fail. Net margin -67628.0% (FY ending 2026-06-30), below the 10% threshold
    • 3. Profit that turns into cash: unknown. Free cash flow or net profit is missing for the period
    • 4. Little debt: unknown. Net debt cannot be measured: no aligned balance sheet with debt and cash
    • 5. Liquid enough to trade: fail. A$5k average daily turnover over 20 sessions, below the A$250k floor
    • 6. Long-term uptrend: pass. Close A$0.07 vs 200-day average A$0.07 (+2.5%)
    • 7. Revenue not shrinking: fail. Revenue -70.4% YoY (FY ending 2026-06-30); revenue shrank

Prices to 7 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial advice

Company

AI-generated research profile of Nanollose

biotechnology
materials science
sustainable textiles
ASX
microbial cellulose

Latest NC6 news

All news

About

website

nanollose.com

address

Suite 5, CPC, 145 Stirling Highway, NEDLANDS, WA, AUSTRALIA, 6009

Connect

More Pharmaceuticals, Biotechnology & Life Sciences Stocks

Other shorted stocks in this sector

TLX
10.8%
TLX
CUV
9.0%
CUV
CU6
8.8%
CU6
MSB
7.5%
MSB
NEU
3.0%
NEU
View all stocks in this industry

Be the first to discuss NC6

Start a research thread or post the first pulse update

Open community